- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Grail Inc (GRAL)
Grail Inc stock price live, this page displays NASDAQ GRAL stock exchange data. View the GRAL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Grail Inc real time stock price chart below.
What Is the Grail Inc Stock Price Today?
The Grail Inc stock price today is 67.87.
What Is the Stock Symbol for Grail Inc?
The stock symbol for Grail Inc is "GRAL."
What Stock Exchange Does Grail Inc Trade On?
Grail Inc is listed and trades on the NASDAQ stock exchange.
Is Grail Inc a Good Stock to Buy?
Determining whether Grail Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GRAL quote. (ISIN: US3847471014)
What Is the Grail Inc Stock Price Today?
The Grail Inc stock price today is 67.87.
What Is the Stock Symbol for Grail Inc?
The stock symbol for Grail Inc is "GRAL."
What Stock Exchange Does Grail Inc Trade On?
Grail Inc is listed and trades on the NASDAQ stock exchange.
Is Grail Inc a Good Stock to Buy?
Determining whether Grail Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GRAL quote. (ISIN: US3847471014)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
66.35
68.71
52 wk Range
29.95
118.84
GRAL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
66.3568.71
52 wk Range
29.95118.84
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GRAL Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
72.38
Upside
+6.64%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock price movements are quite volatile
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
4 Buy
5 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 72.38
(+6.64% Upside)
Grail Inc Earnings Call Summary for Q2/2026
- GRAIL Q2 revenue hit $44.7M, beating estimates by 3.5% with 26% YoY growth; test volume surged 35% to 61,000 tests driven by screening sales.
- Shares dropped 8.33% after-hours despite revenue beat as adjusted EBITDA loss widened to $90.3M from $78.4M YoY; net loss remained $110.2M.
- Company expects FDA advisory committee meeting fall 2026 with potential approval in early 2027, viewed as critical catalyst for payer coverage.
- Cash position stands at $861.6M including $110M Samsung investment; Illumina 7% royalty resumes Q4 2026, potentially impacting 2027 margins.
- Management expanded sales force ahead of FDA decision; average test price fell to ~$700 due to strategic mix shift toward digital health partnerships.
Last Updated: 2026-08-05, 05:32 p/m
Read Full TranscriptEarnings
Latest Release
Aug 05, 2026
EPS / Forecast
-2.56 / --
Revenue / Forecast
44.7M / 43.2M
Compare GRAL to Peers and Sector
Metrics to compare | GRAL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGRALPeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.7x | −14.0x | −0.4x | |
PEG Ratio | −0.31 | −1.25 | 0.00 | |
Price/Book | 1.2x | 6.4x | 2.6x | |
Price / LTM Sales | 18.3x | 21.5x | 3.1x | |
Upside (Analyst Target) | 9.8% | 1.3% | 48.3% | |
Fair Value Upside | Unlock | −38.0% | 6.2% | Unlock |
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Grail (GRAL) Stock Price Today?
The Grail stock price today is 67.87 USD.
What Stock Exchange Does Grail Trade On?
Grail is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Grail?
The stock symbol for Grail is "GRAL."
What Is the Grail Market Cap?
As of today, Grail market cap is 3.03B USD.
What Is Grail's Earnings Per Share (TTM)?
The Grail EPS (TTM) is -9.75.
When Is the Next Grail Earnings Date?
Grail will release its next earnings report on Aug 05, 2026.
From a Technical Analysis Perspective, Is GRAL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Grail Stock Split?
Grail has split 0 times.
How Many Employees Does Grail Have?
Grail has 910 employees.
What is the current trading status of Grail (GRAL)?
As of Aug 16, 2026, Grail (GRAL) is trading at a price of 67.87 USD, with a previous close of 68.24 USD. The stock has fluctuated within a day range of 66.35 USD to 68.71 USD, while its 52-week range spans from 29.95 USD to 118.84 USD.
What Is Grail (GRAL) Price Target According to Analysts?
The average 12-month price target for Grail is 72.38 USD, with a high estimate of 88 USD and a low estimate of 60 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +6.64% Upside potential.
What Is the GRAL Premarket Price?
GRAL's last pre-market stock price is 68.63 USD. The pre-market share volume is 120.00, and the stock has decreased by 0.39, or 0.57%.
What Is the GRAL After Hours Price?
GRAL's last after hours stock price is 68.00 USD, the stock has decreased by 0.13, or 0.19%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.